Cargando…

Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma

Hepatic stellate cells (HSCs), a specialized stromal cytotype in the liver, have been demonstrated to actively contribute to hepatocellular carcinoma (HCC) development. However, the previous studies were performed using HSC cell lines, and the prognostic value of intratumoral HSCs (tHSCs) was unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Bin, Zhang, Xiaofeng, Cheng, Xianshuo, Zhang, Yu, Chen, Lei, Shi, Lehua, Liu, Zhenyu, Qian, Haihua, Wu, Mengchao, Yin, Zhengfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835887/ https://www.ncbi.nlm.nih.gov/pubmed/24278260 http://dx.doi.org/10.1371/journal.pone.0080212

Ejemplares similares

Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
por: Sun, Bin, et al.
Publicado: (2017)

pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma
por: ZHAO, WENXIU, et al.
Publicado: (2012)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma
por: Xu, Minhui, et al.
Publicado: (2014)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
por: Yan, Mengchao, et al.
Publicado: (2023)

Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma
por: Yang, Qiqi, et al.
Publicado: (2017)

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
por: Quiroz Reyes, Adriana G., et al.
Publicado: (2023)

Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
por: Kawada, Norifumi
Publicado: (2015)

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
por: Ren, Chun-Xia, et al.
Publicado: (2017)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers
por: Ji, Weidan, et al.
Publicado: (2011)

Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2020)

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
por: Jouinot, Anne, et al.
Publicado: (2020)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
por: Zhu, Bing, et al.
Publicado: (2015)

Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells
por: WANG, ZHI-MING, et al.
Publicado: (2014)

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
por: Huang, Jian-Hang, et al.
Publicado: (2022)

Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma
por: Ma, Ya-Nan, et al.
Publicado: (2021)

Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
por: Kang, Min-Jung, et al.
Publicado: (2021)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.
por: Evans, T. R., et al.
Publicado: (1994)

Elevated N‐methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform
por: Li, Jie, et al.
Publicado: (2019)

ECM Depletion Is Required to Improve the Intratumoral Uptake of Iron Oxide Nanoparticles in Poorly Perfused Hepatocellular Carcinoma
por: Yeow, Yen Ling, et al.
Publicado: (2022)

HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
por: Chen, Qi-tao, et al.
Publicado: (2022)

Intratumoral CD8(+) Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
por: Chen, Zonglin, et al.
Publicado: (2014)

Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation
por: Ahmed, Osman, et al.
Publicado: (2023)

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia
por: Ma, Hui, et al.
Publicado: (2018)

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
por: Cao, Lu, et al.
Publicado: (2011)

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2013)

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
por: Mogler, Carolin, et al.
Publicado: (2017)

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2010)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma
por: Li, Zhi-Qiang, et al.
Publicado: (2018)

High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma
por: Yang, Yong-Ping, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hphoecerhmskq74fnuad9f76v2